CUA 2020- metastatic Castration sensitive and naïve prostate cancer Flashcards

1
Q

Which patients with prostate cancer should have staging investigations?

A

anyone with high risk features. PSA>20, GS>7, clinical stage T3 or greater.

CT and bone scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is high volume disease based on CHAARTED defenition?

A

> /=4 bone mets with at least one being outside of vertebral bodies or pelvis or presence of visceral metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was latitude definition of high risk?

A

Visceral mets, >/=3 bony mets. or GS>/=8. high risk would be at least two of these criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some other predictors of worse prognosis?

A

appendicular disease (defined as bone lesions in
the chest, skull, and/or extremities), worse performance status,
PSA >65, Gleason score ≥8, high alkaline phosphatase
(ALP), high pain intensity, anemia, and elevated lactate
dehydrogenase (LDH).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what did HORRAD study show?

A

no difference in OS but time to PSA progression was improved. average PSA 140, 67% of patients had more than 5 bone mets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What were the findings of STAMPEDE RT for metastatic prostate cancer study?

A

FFS improved in both high and low metastatic burden,

OS only improved in low metastatic burden. Same criteriae as CHAARTED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are treatment options in addition of ADT for metastatic hormone naive people?

A

High risk or high volume Docetaxel
low volume but good performance status docetaxel is an option(not sure why they put this in GL, no one does this)
Abi can be considered in patients with low volume disease
Abi + prednisone for high risk patients

Enzalutamide and apalutamide are options regardless of volume/risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Should you give Enza with Docetaxel?

A

NO,

But can give it after Docetaxel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does Enzalutamide work?

A

It is AR receptor antagonist that binds to it and prevents AR nuclear translocation and interaction with DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two studies that looked at role of Enza in mCSPC

A
ENZEMAT 
- ADT + NSAA vs ADT+ENZA
-OS survival seen with Enza
ARCHES 
-- primary endpoint was radiological PFS
- benefit was seen in both chemo treated and not chemo treated group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does Apalutamide work?

A

Prevents AR nuclear translocation and DNA binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What were the studies for Apalutamide in this space?

A
TITAN
APA+ADT vs ADT 
improved rPFS
improved OS 
benefit regardless of disease burden
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are recommendations regarding prevention of risk of osteoprosis?

A

All men should get Vitd and calcium , smoking cessation, reduction in alcohol and caffeine intake, increased in weight bearing exercises.

men starting ADT should have bone mineral density scan or DXA scan. Risk calculators such as FRAX should be used. DXA Q 2 years. those with high risk of fractures should get Zolerodnic acid, Alendronate, denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What T scores would be osteopenia on DXA scan? what is Osteoprosis?

A

osteopenia(-1 to -2.5)
Osteoporosis: less than -2.5

The above groups are the ones you want on bone targeted therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly